Clinical Trials Sponsored by Immunitor LLC

Total 10768 results

Immunitor LLC
Immunitor Inc.

Unknown

Tableted COVID-19 Therapeutic Vaccine (COVID-19)

Covid19

Canada, Mongolia
Immunitor LLC
Immunitor Inc.

Unknown

Open Label Trial of Immunotherapy for Advanced Liver Cancer (HCC)

Liver Cirrhosis | HCC

Mongolia
Immunitor LLC

Unknown

Immunotherapy of Chronic Kidney Failure

Renal Failure Chronic

Mongolia
Immunitor LLC

Unknown

Trial of Therapeutic Vaccine in Patients With Cholangiocarcinoma (cholangio)

Cholangiocarcinoma

Mongolia
Immunitor LLC

Unknown

Open Label Immunotherapy Trial for Ovarian Cancer (V3-OVA)

Ovarian Cancer

Mongolia
Immunitor LLC

Unknown

Immunotherapy of Cervical Cancer With V3-Cervix (V3-Cervix)

Cervical Cancer

Mongolia
Immunitor LLC

Unknown

V-Boost Immunotherapy in Glioblastoma Multiforme Brain Cancer (GBM)

Glioblastoma Multiforme | Glioma of Brain

Mongolia
Immunitor LLC

Unknown

Open Label Immunotherapy Trial of Inoperable Pancreatic Cancer (V3-P)

Pancreatic Cancer Non-resectable

Mongolia
Immunitor LLC

Unknown

Open Label Immunotherapy Trial for Breast Cancer (V3-MOMMO)

Breast Cancer

Mongolia
Immunitor LLC

Unknown

Liver Cancer Immunotherapy: Placebo-controlled Clinical Trial of Hepcortespenlisimut-L (Hepko-V5)

HCC | Hepatocellular Carcinoma | Liver Cancer

Mongolia
Immunitor LLC

Unknown

Open Label Immunotherapy of Myoma (V3-myoma)

Leiomyoma | Fibroma | Myoma;Uterus | Fibroid Uterus

Mongolia
Immunitor LLC
Ekomed LLC

Unknown

Open Label Immunotherapy of Endometriosis

Endometriosis

Mongolia
Immunitor LLC
University of Stellenbosch; Lisichansk Regional Tuberculosis Dispensary; National... and other collaborators

Completed

TB Immunotherapy Trial With Heat-killed M. Vaccae (imm03)

Tuberculosis

Mongolia, Ukraine
Immunicon

Unknown

Circulating Tumor Cells and Survival in Hormone Refractory Prostate Cancer (HRPC) Patients Receiving Chemotherapy (IMMC-38)

Prostate Cancer | Hormone Refractory Prostate Cancer

United States
Immunicon

Unknown

Circulating Tumor Cells in Patients With Metastatic Colorectal Cancer (IMMC-06)

Neoplasm Metastasis | Colorectal Cancer

United States
Immunitas Therapeutics

Recruiting

Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or Lymphomas

Follicular Lymphoma | Colorectal Cancer | Hodgkin Lymphoma | Esophageal Cancer | Small Bowel Cancer | Burkitt Lymphoma | Non Small Cell Lung Cancer | Triple Negative Breast Cancer | Diffuse Large B Cell Lymphoma | Head and Neck Squamous Cell Carcinoma | Hormone Receptor Positive Breast Carcinoma | Cutaneous...

United States
Immunicom Inc

Recruiting

A Study Comparing Immunopheresis® Alone or In Combination With Chemotherapy Versus Chemotherapy Alone in Treatment of Advanced Breast Cancer Patients

Advanced Breast Cancer

Poland, Turkey
Immunicom Inc

Recruiting

Immunopheresis Alone or in Combination With Paclitaxel or Atezolizumab in Non-small Cell Lung Cancer (NSCLC).

Non Small Cell Lung Cancer

Turkey
Genetic Immunity

Completed

Single DermaVir Immunization in HIV-1 Infected Patients on HAART (GIHU004)

HIV Infection

Hungary
Immunity Pharma Ltd.

Suspended

A Follow up Study to Protocol 101/2 - Continued Treatment by IPL344 IV

Amyotrophic Lateral Sclerosis (ALS)

Israel
Immunity Pharma Ltd.

Suspended

A Study of IPL344 in the Treatment of ALS Patients (ALS)

Amyotrophic Lateral Sclerosis

Israel
Immunitor LLC
Federal State Budget Institution Research Center for Obstetrics, Gynecology...

Unknown

Vaccine Against Atherosclerosis in Patients With Overweight Problems or Obesity (V6)

Atherosclerosis

Mongolia
Genetic Immunity
Universitätsklinikum Hamburg-Eppendorf

Completed

Repeated DermaVir Immunizations in HIV-1 Infected Treatment-naïve Patients (GIEU006)

HIV Infection

Germany
Lisichansk Regional Tuberculosis Dispensary
National Medical University, Ukraine; Immunitor USA Inc.

Completed

Safety and Efficacy of Oral Immunomodulator in Tuberculosis (TB) and TB/HIV Patients

Tuberculosis

Ukraine
Lisichansk Regional Tuberculosis Dispensary
National Medical University, Ukraine; Immunitor USA Inc.

Completed

Tuberculosis (TB) Immunotherapy Phase 2 Study (imm02)

Tuberculosis

Ukraine
Arthritis Northwest PLLC
Epigenesys LLC

Unknown

Identification of Epigenetic Biomarkers for Early Detection of Rheumatic Disease

Arthritis, Rheumatoid

United States
Angle plc
MidLantic Urology, LLC

Terminated

Characterization of Circulating Tumor Cells (CTCs) in High Risk and Early Metastatic Prostate Cancer Patients Using Parsortix® System (CHARTER)

Prostate Cancer | Castration-resistant Prostate Cancer | Biochemically Recurrent Prostate Carcinoma | High Risk Prostate Carcinoma

United States
Genetic Immunity
IRCCS Policlinico S. Matteo; ViroStatics srl

Completed

Antiretroviral-Sparing Concept With HIV-specific T Cell Precursors With High Proliferative Capacity (PHPC) (PHPC-02)

HIV Infection

Italy
Synochi, LLC
LAC+USC Medical Center

Not yet recruiting

Prospective Placebo-controlled Study of Synochi Scar Spray

Burns Multiple
LLS PedAL Initiative, LLC
Kura Oncology

Not yet recruiting

Ziftomenib in Combination With Chemotherapy for Children With Relapsed/Refractory Acute Leukemia

Relapsed/Refractory KMT2A-r Acute Leukemia | Relapsed/Refractory NUP98-r Acute Leukemia | Relapsed/Refractory NPM1-m Acute Leukemia
Derm Research, PLLC
WFH MEDICAL, LLC

Completed

Aczone 5% Gel as Maintenance Treatment of Acne Vulgaris Following Completion of Oral Doxycycline and Aczone 5% Gel

Acne Vulgaris

United States
Verily Life Sciences LLC
The Emmes Company, LLC; Optos, PLC; Google LLC.; Nikon Corporation

Completed

ARDA Software for the Detection of mtmDR

Diabetic Retinopathy

United States
MedRegen LLC
Johns Hopkins University; ICON plc

Recruiting

MRG-001 as an Immunoregulatory and Regenerative Therapy for COVID-19 Patients

COVID-19 | ARDS, Human | Regeneration | Stem Cells

United States
Redx Pharma Plc
Merck Sharp & Dohme LLC

Completed

A Study to Assess RXC004 Efficacy in Advanced Solid Tumours After Progression on Standard of Care (SoC) Therapy (PORCUPINE2) (KEYNOTE-E86)

Advanced Solid Tumours

United Kingdom, Australia
4D pharma plc
Merck Sharp & Dohme LLC

Terminated

Live Biotherapeutic Product MRx0518 and Pembrolizumab Combination Study in Solid Tumors

Melanoma | Renal Cell Carcinoma | Solid Tumor | Non Small Cell Lung Cancer | Bladder Cancer | Oncology

United States
IVFarma LLC
BridgePharm LLC; GlobalPharma LLC

Completed

Study to Compare Efficacy and Safety of Primapur and Gonal-f in Women for Assisted Reproductive Treatment

Infertility, Female

Russian Federation
Bayside Health
The Peter Doherty Institute for Infection and Immunity

Recruiting

Optimising Cohorts for HIV Cure Interventions (HI-ART)

HIV-1-infection

Australia
Pharmtechnology LLC
ClinPharmInvest, LLC

Not yet recruiting

Bioequivalence Study of Two Formulations of Etoricoxib Tablets 120 mg in Healthy Volunteers Under Fasting Conditions

Bioequivalence

Russian Federation
Pharmtechnology LLC
ClinPharmInvest, LLC

Not yet recruiting

Bioequivalence Study of Two Formulations of Rivaroxaban Tablets 20 mg in Healthy Male Volunteers Under Fed Conditions

Bioequivalence

Russian Federation
Pharmtechnology LLC
ClinPharmInvest, LLC

Completed

Bioequivalence Study of Two Formulations of Atorvastatin Film-coated Tablets 40 mg in Healthy Volunteers Under Fasting Conditions

Bioequivalence

Russian Federation
Pharmtechnology LLC
ClinPharmInvest, LLC

Completed

Bioequivalence Study of Two Formulations of Clopidogrel Film-coated Tablets 75 mg in Healthy Male Subjects Under Fasting Conditions

Bioequivalence

Russian Federation
Pharmtechnology LLC
ClinPharmInvest, LLC

Completed

Bioequivalence Study of Clavamox, Film-coated Tablets, 875 mg + 125 mg Pharmtechnology LLC, Belarus), and Augmentin®, Film-coated Tablets, 875 mg + 125 mg (GlaxoSmithKline Trading CJSC, Russia), in Healthy Volunteers Under Fasting Conditions

Bioequivalence

Russian Federation
Pharmtechnology LLC
ClinPharmInvest, LLC

Completed

Bioequivalence Study of Clavamox, Powder for Oral Suspension, 400 mg + 57 mg / 5 ml (Pharmtechnology LLC, Belarus), and Augmentin®, Powder for Oral Suspension, 400 mg + 57 mg / 5 ml (GlaxoSmithKline Trading CJSC, Russia), in Healthy Volunteers Under Fasting Conditions

Bioequivalence

Russian Federation
Pharmtechnology LLC
ClinPharmInvest, LLC

Not yet recruiting

Bioequivalence Study of Two Formulations of Sildenafil Tablet 100 mg in Healthy Male Volunteers Under Fasting Conditions

Bioequivalence

Russian Federation
IVFarma LLC
NADIM LLC

Completed

The Safety and Pharmacokinetics of Primapur and Gonal-f

Pharmacokinetics | Absorption | Area Under Curve

Russian Federation
Pharmtechnology LLC
ClinPharmInvest, LLC

Completed

Bioequivalence Study of Montelukast, 5 mg Chewable Tablets (Pharmtechnology LLC, Belarus), and Singulair®, 5 mg Chewable Tablets (Merck Sharp & Dohme B.V., the Netherlands), in Healthy Volunteers Under Fasting Conditions

Healthy Adults

Russian Federation
Monsoon Design Studio LLC
Healthark Wellness Solutions LLP

Completed

Study of Evoked Emotional Responses

Emotion, Expressed

India
Pharmtechnology LLC
ClinPharmInvest, LLC

Completed

Bioequivalence Study of Two Formulations of Torasemide Tablet 10 mg in Healthy Volunteers Under Fasting Conditions

Bioequivalence

Russian Federation
AOBiome LLC
bioRASI, LLC

Completed

B244 Topical Spray for the Treatment of Pruritus in Adults With a History of Atopic Dermatitis

Atopic Dermatitis

United States
AOBiome LLC
bioRASI, LLC

Completed

A Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Rosacea

Rosacea

United States

Clinical Trials Sponsored by Immunitor LLC

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Albania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations